Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society
Juan Pedro-Botet; Francisco Arrieta; Manuel Botana; José A. Gimeno-Orna; José I. Martínez-Montoro; Emilio Ortega-Martínez de Victoria; Josep Ribalta; Víctor Sánchez-Margalet; Antonio Pérez-Pérez;
Endocrinol Diabetes Nutr. 2025;72:
Massive switch to an automated insulin delivery system in adults with type 1 diabetes previously treated with sensor-augmented pump due to high risk for hypoglycemia
Alex Mesa; Daria Roca; Montse Granados; Irene Pueyo; Carla Cabré; Antonio J. Amor; Clara Solà; Olga Matas; Júlia Castanys; Ignacio Conget; Marga Giménez;
Endocrinol Diabetes Nutr. 2024;71:390-6
Patient satisfaction in three advanced hybrid closed-loop systems at 6 months of treatment in adults with type 1 diabetes mellitus: a follow-up study
Victor Navas Moreno; Fernando Sebastian-Valles; Miguel Sampedro-Nuñez; Marcos Lahera Vargas; Monica Marazuela; José Alfonso Arranz Martin;
Endocrinol Diabetes Nutr. 2023;70:548-55